Background: Due to extended indications and resynchronization therapy, many implantable cardioverter defibrillator (ICD) recipients will experience progressive co-morbid conditions and will be more likely to die of causes other than cardiac death. It is therefore important to elucidate the ICD patients' preferences when nearing end-of-life. Instead of avoiding the subject of end-of-life, a validated questionnaire may be helpful to explore patients' experiences and attitudes about end-of-life concerns and to assess knowledge of the function of the ICD in end-of-life. Validated instruments assessing patients' perspective concerning end-of-life issues are scarce. Aim: The purpose of this study was to develop and evaluate respondent satisfaction and measurement properties of the 'Experiences, Attitudes and Knowledge of End-of-Life Issues in Implantable Cardioverter Defibrillator Patients' Questionnaire' (EOL-ICDQ). Methods: The instrument was tested for validity, respondent satisfaction, and for homogeneity and stability in the Swedish language. An English version of the EOL-ICDQ was validated, but has not yet been pilot tested. Results: The final instrument contained three domains, which were clustered into 39 items measuring: experiences (10 items), attitudes (18 items), and knowledge (11 items) of end-of-life concerns in ICD patients. In addition, the questionnaire also contained items on socio-demographic background (six items) and ICD-specific background (eight items). The validity and reliability properties were considered sufficient. Conclusions: The EOL-ICDQ has the potential to be used in clinical practice and future research. Further studies are needed using this instrument in an Anglo-Saxon context with a sample of English-speaking ICD recipients.
Introduction
Implantable cardioverter defibrillators (ICDs) have been the treatment for choice for patients at risk of lifethreatening arrhythmias for over 20 years. When these are combined with cardiac resynchronisation therapy (CRT) in heart failure patients, symptom burden and survival are improved. 1 This implies that the ICD recipients will be older. Many will experience progressive morbidity and be more likely to die of chronic illness. Seen from this perspective, it is important to elucidate the Development and evaluation of the EOL-ICDQ as a measure of experiences, attitudes and knowledge in end-of-life in patients living with an implantable cardioverter defibrillator ICD patients' knowledge and preferences about deactivation when nearing end-of-life. There are several obstacles to effective communication and patient education regarding this issue. Firstly, many professionals still feel uncomfortable discussing end-of-life with their patients 2, 3 and lack the competence and skills to communicate about end-of life issues. 4 Secondly, professionals may feel uncertain about if and/or when patients prefer to discuss generator replacement and deactivation, which could result in a delayed end-of-life discussion. 5 Therefore, a validated questionnaire may be helpful to explore patients' experiences and attitudes about end-of-life concerns and assess knowledge of the function of the ICD in end-of-life. A validated questionnaire could also provide professionals with information about the appropriate timing for these discussions. Moreover, such a questionnaire may be useful as a communication tool assist the patient to reflect on end-of-life issues.
Many health instruments have been constructed with a focus on the information needs of professionals and researchers, while patients have not been seen as important partners in the construction process. 6 From the professionals' standpoint, an instrument needs to have good measurement properties, be easy to use, and be functional for clinical practice. However, over the years, it has become increasingly difficult to achieve high participation in surveys, 7 and it is therefore important to satisfy the needs and expectations of patients. In order to be a trustworthy instrument the questions need to be valid and relevant from the patients' point of view, and the questionnaire should be stated in a way that patients feel secure to give truthful and honest answers. 8 Validated instruments testing patients' attitudes concerning end-of-life issues are rare, but Conelius 9 recently developed a survey aiming to determine ICD recipients' preferences, barriers to completion, and understanding of advanced directives. Also Kirkpatrick et al. 10 developed a questionnaire focusing on advanced directives, including the living will and healthcare power of attorney, but this survey was primarily based on expert validation. Others have used scenarios and purpose-design questions to ascertain patients' knowledge about deactivation 11 and their opinions regarding withdrawal of therapy at the end-of-life. [11] [12] [13] Finally, Herman et al. 14 reported a questionnaire about expected ICD benefits, feelings and circumstances under which the ICD recipient would want to deactivate the ICD. Even if one of the existing instruments had been validated in terms of factor structure and test-retest reliability, 9 none have included the patients' perspectives during the whole construction process. To our knowledge, no instrument exists which is aimed at measuring (a) experiences and preferences about when and how discussions about ICD at end-of-life should be raised, (b) attitudes to deactivation and withdrawal of therapy, and (c) knowledge about ICD-therapy at end-of-life.
Aim
The purpose of this study was to develop and evaluate respondent satisfaction and measurement properties of the Experiences, Attitudes and Knowledge of End-of-Life Issues in Implantable Cardioverter Defibrillator Patients Questionnaire (EOL-ICDQ).
Methods

Design and setting
This study was conducted using a methodological design. The EOL-ICDQ was developed and evaluated in a Swedish setting. The construction of this questionnaire involved three phases and took place from 2010-2012 ( Figure 1 ). Finally, a translation/back-translation from Swedish to English was performed.
Participants
Respondents were invited to participate if their ICDs had been implanted for ≥6 months and they were not in the palliative phase of a terminal illness. They were identified from medical records and the booking systems of five Swedish hospitals (pilot) and from the Swedish ICD and Pacemaker registry (test-retest). To achieve maximal variation in the samples, 15 quota sampling was performed to ensure a broad range of background characteristics that were considered important, including: age, gender, marital status, education, aetiology, time since first implantation, prior generator replacement, and prior experience with defibrillator shocks. A letter with written information about the study and an invitation to participate was sent to representative patients. Two to three weeks following the completion of the informed consent, the respondents were mailed the questionnaire. The participants in the pilot were asked to complete a related survey evaluating respondent satisfaction with the questionnaire. The test-retest participants were asked to complete the questionnaire twice, with the second questionnaire being mailed out 2-3 weeks after completion of the first one. The participants were informed in writing about the purpose and the structure of the study before they gave their informed consent. Participation was voluntary and the participants were informed that they could withdraw from the study at any time. The investigation was approved by the Regional Ethics Committee for Human Research at the University of Linköping, Sweden (D-nr 2010/321-31 and D-nr 2011/434-31) and conformed with the principles outlined in the Declaration of Helsinki. 16 
Questionnaire development and evaluation
Phase I. The content in this self-administered questionnaire was based upon the results of a previous qualitative study by the authors 17 and an extensive literature review. The themes emerging from the literature review included (a) patients' experiences of the discussion of deactivation with healthcare professionals, and (b) patients' attitudes about deactivation. The qualitative study additionally revealed themes about (c) patients' understanding of the ICD in an end-of-life setting. A pool of items and a definition of each of the domains included in the questionnaire was drafted. The investigators; a group of five interdisciplinary clinicians and clinical researchers (nurses and physicians) who specialized in ICD care, one statistician skilled in survey design, and one ICD recipient met several times to discuss the layout, content, and response alternatives in the preliminary questionnaire. The discussions resulted in the decision to include questions about both device deactivation and withdrawal of therapy at battery end-of-service. The investigative group also decided to add items related to discussions of end-of-life choices with the family.
The items in the questionnaire were written as clear, brief statements with two or three response alternatives and were divided into three domains: experiences about end-of-life issues; attitudes about discussions and actions;
and knowledge about the ICD in relation to end-of-life. The preliminary questionnaire consisted of 37 items. In addition, optional items on socio-demographic background (six items) and ICD-specific background (eight items) were developed. The preliminary questionnaire and the background questions were given to seven clinical experts within nursing and cardiology for review and comment. Based on their suggestions, an additional knowledge item was added and three items were reworded due to potential misinterpretation of content. The expert panel concluded that the instrument had good face and content validity.
Phase II. To evaluate and improve respondent satisfaction with the questionnaire, 32 patients (19 men and 13 women, median age 63 years, range 33-85) were recruited to (a) complete the questionnaire and (b) complete a separate evaluation survey. They were instructed to validate each item in the questionnaire regarding relevance, clarity, readability and completeness, as suggested by Polit and Beck. 18 Survey questions included: 'Is the question relevant for you as an ICD recipient?'; 'Can the question be interpreted in several ways?'; 'Are the reply alternatives in the question appropriate for you to give your answer?'; and 'Is the question perceived as too sensitive?'. To gain a deeper understanding of respondent satisfaction, cognitive interviews were performed by telephone with three participants using the 'Thinking aloud technique'. 19 The patients were sent the questionnaire in advance and asked to fill it in during the interview. They were invited to comment on immediate thoughts that arose during the completion of the questionnaire. Probing questions were used to clarify or explore responses during the interview.
The questionnaire was judged by the participants to be relevant, user-friendly, clear, readable and easy to complete. None of the participants considered any of the questions as too sensitive to answer. Two questions were rephrased following the cognitive interviews. One new item was added to the attitude domain to address the preferred timing of a discussion about the process of deactivation. One item was added to the experience domain regarding philosophy of life. These modifications were based on comments made by participants during the interviews as these concepts were identified as being important in this setting. After these adjustments, again one patient validated the questionnaire without having any new comments on the content or the reply alternatives in the questionnaire.
Phase III. The final questionnaire was evaluated for measurement properties. To test reproducibility, 109 patients (Table 1 ) were asked to complete the final questionnaire twice, within a time interval of 2-3 weeks. The final version contained three domains measuring experiences of end-of-life issues (10 items), attitudes about discussions and actions (18 items) and knowledge of the ICD in relation to end-of-life (11 items, divided into ethical aspects, function of the ICD, and practical consequences). The respondents listed their answer in an unforced-choice format as 'Yes/No' or 'Can't take a stand', 'Agree/Don't agree', 'True/False' or 'Don't know'. Items belonging to the experience and attitude domains were single items while items belonging to the knowledge scale are sum scores. The optional questions on socio-demographic background included age, gender, ethnicity, marital status, occupational status and educational level (six items). Items related to ICD-specific background included time since implantation, cardiac resynchronization therapy, primary or secondary prevention therapy, generator replacement, perceived general health, general satisfaction with the ICD, experience of shock therapy and a rating of the severity of shock-induced pain and/or anxiety (eight items).
Statistical analyses
Descriptive statistics were used to describe the distribution of item responses and patterns of missing data. The reproducibility (test-retest reliability) was evaluated using kappa statistics. An unweighted kappa was calculated as the items consisted of dichotomous or non-ordered response categories. The agreement according to the kappa statistics were interpreted as follows: poor <0.20; fair 0.20-0.40; moderate 0.40-0.60; good 0.60-0.80; and very good 0.80-1.00. 20 As the knowledge domain uses the total score as a measure of knowledge, correct answers were coded as 1 while incorrect answers including the alternative 'I don't know' were coded as 0. The score for the 11 items was then summed as a total score. The Kuder-Richardson formula 20 (KR20) was calculated to evaluate internal consistency of the items in the knowledge domain. A sufficient level of KR20 was set to ≥0.70. In addition, the items in the knowledge domain were also evaluated regarding difficulty level and discriminability. 21 The difficulty level of each item was evaluated using the item difficulty index (IDI). This index represents the proportion of participants who answered the item correctly, i.e. higher values imply easier items. To evaluate item discriminability, item discrimination coefficients were calculated. For this purpose, the point biserial correlation (r pb ) between the performance on the individual item and the overall test was used. Stronger correlations imply better discriminability. A sufficient level of the item discrimination index was set to r pb ≥0.30.
Translation procedure. The questionnaire was translated into an American English version through a translation/ back-translation procedure. 22, 23 First, a native English speaker fluent in both languages translated the questionnaire into English, and then a native Swedish speaker fluent in both languages re-translated it into Swedish, with no previous knowledge of the original survey. Differences between the English version and the re-translated Swedish version, as well as possible cultural differences were discussed with all investigators in order to improve the quality of the English version. 22, 23 Finally, the English version of the EOL-ICDQ was linguistically tested and expertly validated for face and content validity with three native-English speaking researchers in the US familiar with ICDs. The questionnaire was revised with minor changes in respect to language and cultural differences. The English version was considered to have sound content validity and to be linguistically equivalent to the Swedish version.
Results
Measurement properties
Experience of end-of-life issues. The number of missing data points was low (<1%) and concentrated to three of the (Table 2) .
Attitudes about discussions and actions. In the attitudes about discussions, i.e. when the patients would like professionals to broach the question of what it involves to turn off the defibrillation shocks in the ICD, missing data was found for all items except 'Towards end-of-life, during the last days' (item 10). The missing values were equally distributed across the items with 1-3 data points missing from each (1.5%). The item 'I myself will raise the question when I feel the need to' (item 2) was most skewed. Most items had a moderate (items 4, 5, 7-9) or fair (items 1, 3, 6, 10) reproducibility. One item demonstrated poor reproducibility (item 2) ( Table 3 ).
In the attitudes about actions, i.e. generator replacement and deactivation, missing data was demonstrated in five out of eight items (1%). The frequency of missing data was low, but still most common for the item 'At the end of my life, I want my next-of-kin to decide if the shocks are to be turned off' (item 18). Regarding the distribution of scores between the Yes and No alternatives, little variation was shown for the items; 'I want to have the battery in my ICD replaced even if I have not received any shocks' (item 11), 'I want to have the battery in my ICD replaced even if I Table 4 ).
The knowledge scale. Only one item in the knowledge scale had missing data, 'In order to turn off the shocks in an ICD, the ICD must be removed by surgery' (item 1). According to KR20, the internal consistency was 0.697, close to the acceptable level of ≥0.70. Except for one item, 'An ICD always delivers shocks in connection with endof-life' (item 9), the distribution of the scores showed that most participants chose the True or False alternative. A large share of the respondents chose the Don't know alternative on this item. This response alternative was also common for the item 'A magnet can be used to temporarily turn off the ICD's shocks' (item 6). The IDI showed a satisfactory variation, the least difficult item was 'When an ICD's shocks are turned off, the heart stops beating' (item 3, IDI=0.88) while the most difficult item was 'An ICD always delivers shocks in connection with end-of-life' (item 9, IDI=0.30). All items demonstrated acceptable discriminability according to the critical level of the item discrimination coefficient (r pb >0.30) ( Table 5) .
Experiences, attitudes, and knowledge in relation to end-oflife.
Overall, 40% of respondents had discussed the illness course with their physician. Eleven per cent had discussed what turning off the shocks involves with someone on the ICD-team and 14% had discussed the same topic with their family. Eleven per cent had also told their next-of-kin their wishes regarding shock therapy if they should become seriously ill with some fatal disease. When it came to the participants' attitudes on discussing deactivation and endof-life issues, 29% were unwilling to have such a conversation, 61% stated that the question should be raised in connection with the ICD-implantation, and 70% during the last days of life. The vast majority would like to replace the ICD at end-of-service, even if: no shocks have been delivered (84%); they are seriously ill with another disease (58%); or have reached an advanced age (71%). One-third of the participants (31%) were indecisive about deactivating the ICD if dying from cancer or other serious disease, and 46% were unable to take a stand about whether or not to keep the ICD active if receiving shocks daily. On the other hand, 26% favoured an active ICD at end-of-life and 43% preferred deactivation under those circumstances. Finally, the participants were most knowledgeable about the statement; 'When the shocks are turned off, the heart stops beating', with 83% correctly answering no. Lowest levels of knowledge were found in relation to the question 'When an ICD's battery voltage is beginning to wear, the ICD's functioning worsens', with 40% falsely answering true. Forty-eight per cent of participants were indecisive about the false statement; 'An ICD always delivers shocks in connection with end-of-life'.
Discussion
The EOL-ICDQ was developed to assess patients' knowledge of the ICD in relation to end-of-life as well as their experiences and attitudes about such issues. To ensure the participants' trust and confidence, efforts were made to involve patients in several steps of the construction and validation process. Validity was supported by the fact that the items were assessed to be adequate by the experts and patient in the research group and the participants in terms of the relevance and the focus of the study. The participants reported that the questionnaire was clear, easy to read and complete, and can thus be considered a userfriendly questionnaire The evaluation of the EOL-ICDQ showed that the items had sound measurement properties in terms of reproducibility. Although a few items showed poor or fair reproducibility according to the kappa statistics, the absolute agreement was high. One reason for this discrepancy is that kappa statistics takes the agreement occurring by chance into account. The kappa statistics can therefore be considered a conservative test, in particular when the score distribution is highly skewed. This is for example reflected in the item 'I myself will broach the question when I feel the need to' (item 2) which had the most skewed distribution, the highest absolute agreement, and lowest kappa value in the attitudes about discussions. However, it is possible that the reproducibility of the scale over time with a 2-3 week span was too long. Ideally, this time frame should be 2-14 days. 24 The knowledge scale showed sufficient measurement properties. The use of the response 'Don't know' can probably explain the low number of missing data. Another strength of using this response alternative is that it can reduce the number of persons choosing a correct answer by chance. To calculate a total score for persons who used this alternative, an assumption was made that the person did not have the knowledge necessary to answer the question and the alternative was scored as an incorrect answer. The large share of the persons who scored 'Don't know' on item 6 and item 9 may reflect increased item difficulty or decreased item clarity. However, the IDI showed that no item in the knowledge scale was too easy (≥90) or difficult (≤10). The variation in item difficulty levels indicate that discriminability of the knowledge scale is appropriate. This postulate is also supported by the item discrimination coefficients; all items had a correlation r pb ≥0.3. 20 One third of the participants were reluctant to discuss end-of-life issues, but according to existing expert consensus statements, 25, 26 a discussion about deactivation should already take place at the time of ICD-implantation. Furthermore, one-quarter of the participants preferred to maintain ICD shocks at end-of-life. This highlights the importance of being aware of the patient's unique preferences and needs; something that earlier has been described as important also from the professionals' perspective when delivering care to ICD recipients. 27 Many of our participants were indecisive about their standpoint on deactivation. In clinical practice, it may be prudent for the patient to answer the questionnaire before presenting to the clinic. This may facilitate reflection, allowing the ICD recipient to be better prepared for a discussion with the ICD team. 
Methodological issues
It is a challenge to develop a questionnaire based on a scientific approach to uncover sensitive existential issues. We are aware of the dynamic nature of human experiences, attitudes and knowledge over time and the implications of such a nature on the understanding of the questionnaire and the application of it. However we think that the EOL-ICDQ is valid in a Swedish setting and will provide a different and more humane perspective of the needs of ICD recipients.
The construction and testing of the EOL-ICDQ provided evidence of good psychometric properties. The findings provide satisfactory support for content validity, respondent satisfaction and good reproducibility. Quota sampling strengthened the internal validity of this by providing maximal variation in the sample. Participants were not near the end-of-life. Most of the patients stated that they felt they were in a 'good' or 'very good' state of health. This could have created a selection bias against patients with co-morbidities. However, when the participants reported their co-morbidities, several indicated diabetes, lung problems and kidney failure, with every tenth patient reporting a current diagnosis of cancer. This may imply that the questionnaire can be used in different stages of an illness trajectory.
Conclusion
In clinical practice, the EOL-ICDQ can be used as a tool which opens for the possibility to go into a dialogue with healthcare professionals to create interactions and communication with ICD recipients. It could be used as an initial assessment of experiences, attitudes and knowledge about end-of-life issues, and an educational tool at subsequent visits. This would allow for the evaluation of changes in knowledge or attitudes towards battery replacement and withdrawal of therapy. Further studies are needed to test the instrument's usability as a communication tool in patients nearing end-of-life. Continued research with this questionnaire in clinical practice is important, as the instrument addresses a clinically relevant concern that has been relatively unexplored. Further studies are also needed to test this instrument in a sample of English speaking ICD recipients.
Implications for practice
EOL-ICDQ can be used as
• a communication tool for discussing experiences and attitudes about end-of-life • a reference point of patients' preferences at endof-life, allowing for continuity of care • an educational tool for accessing knowledge
